A 57-year-old woman with non-small cell lung cancer comes to the physician 4 weeks after her tumor was resected. She takes no medications. The physician starts her on a treatment regimen that includes vinblastine. This treatment puts the patient at highest risk for which of the following?

Question

Quizplus · Accepted Answer

Eductional Objective: A major adverse effect of vinblastine is myelosuppression, which can result in leukopenia and subsequent immunosuppression. Therefore, treatment with vinblastine increases the risk of opportunistic infections, such as invasive aspergillosis. Myelosuppression is the most common dose-limiting effect of chemotherapeutic agents.

A 57-Year-Old Woman with Non-Small Cell Lung Cancer Comes to the Physician